bmi, body weight
Item
obesity: defined as subjects having a body mass index greater than 30 kg/m(2). weight must be less than 300 lb (136 kg) because of limits related to the dxa and ct scanners.
boolean
C1305855 (UMLS CUI [1])
C0005910 (UMLS CUI [2])
type 2 diabetes, impaired glucose tolerance, hyperinsulinemia
Item
patients with type 2 diabetes, impaired glucose tolerance, or hyperinsulinemia are eligible.
boolean
C0011860 (UMLS CUI [1])
C0020459 (UMLS CUI [2])
C0271650 (UMLS CUI [3])
age
Item
patients' age must be greater than or equal to 18 years at the start of the study.
boolean
C0001779 (UMLS CUI [1])
liposuction
Item
patients must be planning to undergo large volume liposuction.
boolean
C0038640 (UMLS CUI [1])
pregnancy test, contraception
Item
premenopausal women participating in the study must have a negative pregnancy test at the start of the study and will be required to remain on some form of effective contraception for the duration of the study.
boolean
C0032976 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
race
Item
patients recruited for the pilot study will be required to have all four grandparents and both parents to be either all non-hispanic caucasians or non-hispanic african-american.
boolean
C0034510 (UMLS CUI [1])
renal disease, creatinine clearance, serum creatinine
Item
volunteers with the presence of significant, unstable or evolving renal disease are not eligible. subjects must not have calculated (age and weight corrected) creatinine clearances below 50 ml/min or significant worsening of serum creatinine levels during the course of the study (greater than 30% increase from baseline).
boolean
C0022658 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
ast, alt
Item
volunteers with the presence of significant, unstable or evolving hepatic disease associated with sgot and/or sgpt greater than 2.5 times normal are not eligible.
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
heart disease, nyha
Item
volunteers with the presence of significant, evolving or unstable cardiac disease are not eligible. subjects with nyha stage 3 or 4 disease will be excluded from the study.
boolean
C0018799 (UMLS CUI [1])
C1275491 (UMLS CUI [2])
pulmonary disease
Item
volunteers with the presence of significant, evolving or unstable pulmonary disease including uncontrolled bronchial asthma and/or chronic bronchitis are not eligible.
boolean
C0024115 (UMLS CUI [1])
comorbidity
Item
volunteers with the presence of other uncontrolled or unstable medical conditions including uncontrolled thyroid disease, cushing's syndrome, autoimmune or gastrointestinal disease are not eligible.
boolean
C0009488 (UMLS CUI [1])
pregnancy
Item
volunteers who are pregnant are not eligible.
boolean
C0032961 (UMLS CUI [1])
type 2 diabetes
Item
volunteers must not have uncontrolled type 2 diabetes as evidenced by recent coma or pre-coma states, frequent episodes of hypoglycemia, predominantly severe hyperglycemia (plasma glucose greater than 400 mg/dl) in the past three months prior to study commencement, a glycosylated hemoglobin (hba1c) value greater than 10 in the past three months prior to the study commencement, and frequent or recurrent episodes of ketosis (ketonuria and/or ketonemia).
boolean
C0011860 (UMLS CUI [1])
mental disorders
Item
volunteers with uncontrolled, significant or evolving psychiatric/psychological syndromes which in the opinion of the investigators would place the patient at increased risk during the course of the study or would impede competence and/or ability to complete the study are not eligible.
boolean
C0004936 (UMLS CUI [1])
substance abuse
Item
volunteers with current history of illicit substance abuse and/or alcoholism based on reported history and the cage questionnaire are not eligible.
boolean
C0038586 (UMLS CUI [1])
medication
Item
volunteers must not have a recent use (within the preceding 6 months) of anorexiant medications or medications that would affect nutrient absorption such as orlistat or acarbose.
boolean
C0013227 (UMLS CUI [1])
medication
Item
volunteers must not be receiving treatment with an insulin-sensitizing medication such as metformin or the thiazolidinediones. use of insulin, meglitides or the sulphonylureas will not constitute an exclusion.
boolean
C0013227 (UMLS CUI [1])
menstruation
Item
volunteers with an absence of spontaneous menses for greater than 1 year are not eligible.
boolean
C0025344 (UMLS CUI [1])